Candriam S.C.A. Neogenomics Inc Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Neogenomics Inc stock. As of the latest transaction made, Candriam S.C.A. holds 467,026 shares of NEO stock, worth $8.39 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

467,026

Previous 487,026 4.11%

Holding current value

$8.39 Million

Previous $6.76 Million 1.97%

% of portfolio

0.04%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$13.4 - $17.73 $268,000 - $354,600	-20,000 Reduced 4.11%	467,026 $6.89 Million
Q2 2024 Aug 05, 2024	BUY	$13.01 - $15.77 $1.46 Million - $1.77 Million	112,009 Added 29.87%	487,026 $6.76 Million
Q1 2024 May 03, 2024	BUY	$14.06 - $16.79 $2.39 Million - $2.85 Million	170,010 Added 82.93%	375,017 $5.9 Million
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $2.39 Million - $4.25 Million	205,007 New	205,007 $3.32 Million
Q1 2023 May 12, 2023	SELL	$9.09 - $19.45 $463,844 - $992,494	-51,028 Reduced 66.37%	25,851 $450,000
Q4 2022 Feb 13, 2023	SELL	$6.45 - $12.07 $138,268 - $258,744	-21,437 Reduced 21.8%	76,879 $710,000
Q3 2022 Nov 10, 2022	BUY	$7.86 - $12.91 $772,763 - $1.27 Million	98,316 New	98,316 $847,000
Q1 2022 May 13, 2022	SELL	$12.15 - $35.28 $3.26 Million - $9.46 Million	-268,194 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$30.49 - $48.49 $246,176 - $391,508	8,074 Added 3.1%	268,194 $9.15 Million
Q3 2021 Nov 09, 2021	BUY	$41.66 - $52.52 $3.03 Million - $3.82 Million	72,788 Added 38.86%	260,120 $12.5 Million
Q2 2021 Jul 20, 2021	SELL	$36.62 - $51.69 $4 Million - $5.64 Million	-109,187 Reduced 36.82%	187,332 $8.46 Million
Q1 2021 Apr 29, 2021	SELL	$41.56 - $59.88 $374 - $538	-9 Reduced -0.0%	296,519 $15.3 Million
Q4 2020 Jan 22, 2021	BUY	$36.08 - $56.47 $9.44 Million - $14.8 Million	261,545 Added 747.63%	296,528 $16 Million
Q3 2020 Oct 19, 2020	SELL	$33.26 - $40.48 $17.5 Million - $21.3 Million	-527,115 Reduced 93.78%	34,983 $1.29 Million
Q2 2020 Jul 23, 2020	BUY	$24.21 - $31.02 $2.31 Million - $2.96 Million	95,433 Added 20.45%	562,098 $17.4 Million
Q1 2020 May 26, 2020	BUY	$20.5 - $34.53 $1,660 - $2,796	81 Added 0.02%	466,665 $13.3 Million
Q4 2019 Jan 21, 2020	BUY	$18.96 - $29.84 $3.91 Million - $6.16 Million	206,383 Added 79.32%	466,584 $14,000
Q3 2019 Oct 21, 2019	BUY	$19.12 - $26.24 $1.61 Million - $2.2 Million	84,000 Added 47.67%	260,201 $5,000
Q2 2019 Aug 01, 2019	BUY	$19.57 - $24.1 $841,510 - $1.04 Million	43,000 Added 32.28%	176,201 $3.85 Million
Q1 2019 May 02, 2019	BUY	$12.14 - $20.46 $1.62 Million - $2.73 Million	133,201 New	133,201 $2.73 Million

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.26B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account